Biofeedback CBT Insomnia Patent Application EP4396832A1

The EPO published patent application EP4396832A1 covering biofeedback cognitive behavioral therapy systems and methods for treating insomnia, filed by Resmed Digital Health Inc. with inventors Redmond Shouldice, Kieran Conway, Michael Wren, and Stephen Dodd. The application is classified under G16H 20/00 (Health Informatics for digital therapeutics) and designates all European patent states including Germany, France, the United Kingdom, Italy, Spain, and 27 other countries.\n\nHealthcare providers and technology companies developing insomnia or sleep disorder digital health solutions should monitor this patent publication for competitive landscape awareness. While patent applications require future examination before grant, the published claims indicate the scope of intellectual property being pursued in the biofeedback CBT digital therapeutics space.